Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway

Breast cancer is one of the most prevalent malignancies and the leading cause of cancer-associated mortality in women worldwide and in China. Everolimus (C(53)H(83)NO(14)) is an efficient anti-cancer drug for breast cancer which targets mammalian target of rapamycin (mTOR). The present study investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Liyan, Li, Xiaomei, Zhen, Linhong, Chen, Weiling, Mu, Lingguang, Zhang, Yang, Song, Ailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928673/
https://www.ncbi.nlm.nih.gov/pubmed/29568883
http://dx.doi.org/10.3892/mmr.2018.8769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928673/
https://www.ncbi.nlm.nih.gov/pubmed/29568883
http://dx.doi.org/10.3892/mmr.2018.8769

Ejemplares similares